Pinealon

Mechanism (as reported)

A study reported that pinealon suppresses reactive oxygen species (ROS) accumulation and is accompanied by delayed ERK 1/2 activation and cell-cycle modification, with effects described as saturated for ROS/cell mortality at lower concentrations while cell-cycle modulation persisted at higher concentrations (PMID 21978084). A review described a hypothesis that the EDR peptide enters cells and binds to histone proteins and/or ribonucleic acids, potentially changing MAPK/ERK signaling, antioxidant enzyme–related proteins, and other factors connected to Alzheimer’s disease pathogenesis (PMID 33396470). A study reported fluorescence-labeled peptide signal in the cytoplasm, nucleus, and nucleolus after incubation with HeLa cells, and in vitro peptide interactions with deoxyribooligonucleotides/DNA that differed by peptide structure and appeared sequence- and methylation-status–dependent (PMID 22117547). Additional sources described pinealon antihypoxic effects as involving stimulation of internal antioxidative enzyme systems and possibly limiting excitotoxic effects of N-methyl-D-aspartate, rather than only ROS inhibition (PMID 18546825).

Key findings (each cites a source)

• Research investigated pinealon (Glu-Asp-Arg) and reported reduced ROS accumulation and decreased necrotic cell death in cerebellar granule cells, neutrophils, and PC12 cells under oxidative stress, alongside delayed ERK 1/2 activation and cell-cycle modification. [PMID 21978084]
• A review described the EDR peptide (Glu-Asp-Arg) as activating gene expression and protein synthesis involved in maintaining neuronal functional activity and reducing apoptosis intensity in in vitro and in vivo studies; it also described effects on dendritic spine elimination and reported increased antioxidant enzyme synthesis in cerebellum neuron cultures (rats). [PMID 33396470]
• A review/article described a hypothesis that EDR peptide may enter cells and bind histone proteins and/or ribonucleic acids, potentially altering MAPK/ERK signaling and related proteins/transcription factors cited in the review. [PMID 33396470]
• A study using fluorescence-labeled short peptides reported that incubation with pinealon (Glu-Asp-Arg) produced marked fluorescence in cytoplasm, nucleus, and nucleolus in HeLa cells, and it reported in vitro specific interactions between short peptides and DNA/deoxyribooligonucleotides (including differences by nucleotide sequence and cytosine methylation status). [PMID 22117547]
• Research investigated antihypoxic properties of short regulatory peptides and reported that pinealon (Glu-Asp-Arg) showed the most pronounced effect in a hypobaric hypoxia model; the reported basis was complex and included stimulation of internal antioxidative enzyme systems and possibly limiting the excitotoxic effect of N-methyl-D-aspartate. [PMID 18546825]
• A study in rats reported that pinealon showed a prevalent positive effect on learning in the Morris labyrinth compared to cortexin, and it also reported regional changes in caspase-3 activity/content in brain structures across young and old rats under peptide influence. [PMID 28976148]
• A study described geroprophylactic effects of short synthetic tripeptides including pinealon in 32 participants with polymorbidity and organic brain syndrome in remission, reporting significant anabolic effects and improved activity of the central nervous system and other organs as indicators used to slow aging by biological age indicators; it also reported prooxidant activity by chemiluminescence and noted that pinealon and vesugen did not affect chromatin condensation (reported as a nuclear genetic level property). [PMID 26390612]
• An occupational medicine study reported that application of bioregulating peptides (combined application of several cytogens including pinealon and vesugen) was found to restore adaptive potential, improve psychoemotional indices, intensify resistance to work stress, and reduce occupational risk of borderline mental disorders in their reported analysis; it also described that lorry-drivers had higher prevalence of certain psychoadaptive disorder categories compared with a control group. [PMID 23734521]